Pelican Ridge Post Acute gave the resident dextrose intravenous solution on September 15, but the family member discovered the IV therapy only when visiting and seeing the fluids infusing into the resident's vein.
The resident's cognitive assessment showed a score of 6, indicating severe impairment that would prevent her from making informed treatment decisions. Her family member told inspectors during a September 30 phone interview that "the IV fluids were given to Resident 2 without her knowledge."
The family member said she "was not informed of the IV fluid therapy and was afraid the IV therapy posed a dangerous risk for the resident." She only learned about the treatment when she saw the IV bag during a visit.
Medical records show the physician ordered 1,000 milliliters of dextrose intravenous solution on September 15, followed by another order the next day for the same solution with multivitamins to infuse at 60 milliliters per hour. Dextrose is a sterile mixture of glucose and water given directly into a patient's vein.
The resident received the first IV treatment at 8:03 p.m. on September 15. But inspectors found no documentation that staff informed the family member about the physician's order, explained the potential effects of the IV therapy, or offered alternative treatment options.
When inspectors interviewed the registered nurse who had verified the resident received the dextrose solution, she said she "was not sure why the resident was started on IV therapy." The nurse confirmed that medical records contained no documented evidence explaining why the physician ordered the IV fluids or showing that staff had notified the family member about the treatment.
The nursing home's failure meant the family member could not participate in treatment decisions for a resident who lacked the cognitive ability to understand her care options. Federal regulations require facilities to ensure residents or their representatives are fully informed about proposed treatments, including risks, benefits, and alternatives.
IV fluid therapy carries potential complications, particularly for elderly residents. The dextrose solution can affect blood sugar levels and fluid balance. Without proper informed consent, family members cannot weigh these risks against potential benefits or request alternative treatments that might be safer or more appropriate.
The resident's medical records showed no indication for why the dextrose IV was necessary, raising questions about whether the treatment was medically justified. The nurse's admission that she didn't know why the therapy was started suggests a lack of communication between medical staff about treatment rationales.
This breakdown in communication extended to the family. The family member's fear that the IV therapy "posed a dangerous risk" reflects the anxiety that can result when medical treatments are administered without explanation or consent. Her discovery of the treatment during a casual visit, rather than through proper notification, violated basic principles of patient rights and family involvement in care decisions.
The director of nursing acknowledged the findings when interviewed on October 3. However, the inspection report provides no indication that the facility had policies or procedures in place to prevent similar lapses in informed consent for future treatments.
The violation occurred despite clear federal requirements that residents must be fully informed about their health status, care, and treatments. For residents with cognitive impairment, this responsibility extends to their designated representatives, who must receive the same detailed information about proposed treatments.
The case highlights how communication failures in nursing homes can leave families in the dark about significant medical interventions. When a registered nurse admits uncertainty about why a treatment was ordered, and medical records lack documentation of the clinical rationale, it suggests systemic problems with treatment planning and family notification.
The family member's statement that she was "afraid" the IV therapy was dangerous underscores the emotional impact of discovering undisclosed medical treatments. Her concern was reasonable given that she had no information about why the IV was necessary, what it contained, or what risks it might pose to her cognitively impaired family member.
Inspectors classified this as a violation with minimal harm or potential for actual harm. But the failure to obtain informed consent for IV therapy represents a fundamental breach of patient rights that could have prevented the resident and her family from making crucial decisions about her medical care.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Pelican Ridge Post Acute from 2025-10-06 including all violations, facility responses, and corrective action plans.